Phase I Study of HL-085 in Patients With Advanced Solid Tumors
Clinical trial NCT03976050 · TERMINATED
Trial details
- NCT number
- NCT03976050
- Sponsor
- Shanghai Kechow Pharma, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2020-11-12
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.